Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR.

about

Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR.

Item

http://www.wikidata.org/entity/Q54126967

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Detection of PIK3CA Mutations ...... ra-Sensitive PNA-Mediated PCR.

@en

Detection of PIK3CA Mutations ...... ra-Sensitive PNA-Mediated PCR.

@nl

type

Item

label

Detection of PIK3CA Mutations ...... ra-Sensitive PNA-Mediated PCR.

@en

Detection of PIK3CA Mutations ...... ra-Sensitive PNA-Mediated PCR.

@nl

prefLabel

Detection of PIK3CA Mutations ...... ra-Sensitive PNA-Mediated PCR.

@en

Detection of PIK3CA Mutations ...... ra-Sensitive PNA-Mediated PCR.

@nl

P1476

Detection of PIK3CA Mutations ...... ra-Sensitive PNA-Mediated PCR.

@en

P2093

Li Xie

http://www.w3.org/2001/XMLSchema#string

Min Liu

http://www.w3.org/2001/XMLSchema#string

Na Zhou

http://www.w3.org/2001/XMLSchema#string

Qian Zeng

http://www.w3.org/2001/XMLSchema#string

Xianrang Song

http://www.w3.org/2001/XMLSchema#string

P2860

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Cancer statistics, 2013

High frequency of mutations of the PIK3CA gene in human cancers

A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer.

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer

PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood

Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus.

P2888

s40291-017-0269-9

P304

443-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40291-017-0269-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28247181

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer